Filter Results:
(9,818)
Show Results For
- All HBS Web
(9,818)
- People (25)
- News (1,714)
- Research (6,269)
- Events (39)
- Multimedia (107)
- Faculty Publications (4,599)
Show Results For
- All HBS Web
(9,818)
- People (25)
- News (1,714)
- Research (6,269)
- Events (39)
- Multimedia (107)
- Faculty Publications (4,599)
- July 2010 (Revised January 2017)
- Background Note
Marketing Analysis Toolkit: Customer Lifetime Value Analysis (2024)
By: Thomas Steenburgh and Jill Avery
Customers are increasingly being viewed as assets that bring value to the firm. Customer lifetime value is a metric that allows managers to understand the overall value of their customer base and relate it to three customer strategies firms employ: asset... View Details
Keywords: Customer Lifetime Value; Return On Investment; Customer Acquisition; Customer Retention; Customer Churn; ＂Marketing Analytics＂; Marketing; Customer Relationship Management; Customer Focus and Relationships; Customer Value and Value Chain; Management Analysis, Tools, and Techniques; Marketing Strategy; Measurement and Metrics; Strategic Planning; Value
Steenburgh, Thomas, and Jill Avery. "Marketing Analysis Toolkit: Customer Lifetime Value Analysis (2024)." Harvard Business School Background Note 525-017, July 2010. (Revised January 2017.)
- January – February 2011
- Article
Creating Shared Value
By: Michael E. Porter and Mark R. Kramer
The capitalist system is under siege. In recent years business has been criticized as a major cause of social, environmental, and economic problems. Companies are widely thought to be prospering at the expense of their communities. Trust in business has fallen to new... View Details
Keywords: Customer Value and Value Chain; Economic Growth; Economic Systems; Corporate Social Responsibility and Impact; Environmental Sustainability; Trust; Human Needs; Welfare; Competitive Advantage; Value Creation
Porter, Michael E., and Mark R. Kramer. "Creating Shared Value." Harvard Business Review 89, nos. 1-2 (January–February 2011): 62–77.
- July 2002 (Revised July 2008)
- Case
Value Retail
By: Arthur I Segel and Ani M Vartanian
Scott Malkin, CEO of Value Retail, a developer and operator of European outlet villages serving luxury brands, is planning on developing a 18,503 m2 open-air outlet village to be built 98 kilometers south of Milan on land he was about to acquire for 7.26 million lira.... View Details
Segel, Arthur I., and Ani M Vartanian. "Value Retail." Harvard Business School Case 803-008, July 2002. (Revised July 2008.)
Value Shift
Today, corporate accountability is as vital to the bottom line as an effective business model. Value Shift makes a strong case for the merits of corporate responsibility and shows how a value-positive orientation contributes to superior performance through... View Details
- May 2020 (Revised October 2021)
- Case
Valuing Peloton
Peloton Interactive, a well-known venture-capital-backed unicorn in the connected fitness space, recently had gone public with a market capitalization of over $8.0 billion. However, in the weeks following its public debut, Peloton’s stock price had fallen by over 25%.... View Details
Keywords: Business Model; Public Equity; Initial Public Offering; Disruptive Innovation; Business Strategy; Valuation; Entertainment and Recreation Industry; United States
Mayfield, E. Scott. "Valuing Peloton." Harvard Business School Case 220-060, May 2020. (Revised October 2021.)
- October 2000
- Background Note
Sustaining Value
By: Robert J. Dolan
Describes the challenges a firm faces in building and sustaining a value proposition over time. Describes major ways in which the marketing environment changes over time and the methods a firm can use to protect its market position. View Details
Dolan, Robert J. "Sustaining Value." Harvard Business School Background Note 501-045, October 2000.
- November 2020
- Case
Valuing Celgene's CVR
By: Benjamin C. Esty and Daniel Fisher
When Bristol-Myers Squibb (BMS) acquired Celgene Corporation in November 2019, Celgene shareholders received cash, BMS stock, and a contingent value right (CVRs) that would pay $9 if the U.S. Food and Drug Administration (FDA) approved three of Celgene’s late stage... View Details
Keywords: Mergers and Acquisitions; Value; Valuation; Judgments; Decision Making; Cash Flow; Financial Instruments; Cognition and Thinking; Pharmaceutical Industry; Biotechnology Industry; United States
Esty, Benjamin C., and Daniel Fisher. "Valuing Celgene's CVR." Harvard Business School Case 221-031, November 2020.
- May 2020 (Revised November 2021)
- Supplement
Valuing Peloton
Peloton Interactive, a well-known unicorn in the connected fitness space, had gone public with a market capitalization of over $8.0 billion. In the weeks following its public debut, Peloton’s stock price fell by over 25%. Taylor Knox, a stock analyst and enthusiastic... View Details
- March 1998
- Case
Value Creation: Abridged
By: George P. Baker III, Michael C. Jensen, Karen Wruck and Perry Fagan
Asks students to value a strategic plan while considering the capital investment required to complete the plan. Cummins Engine is used as an example. View Details
Baker, George P., III, Michael C. Jensen, Karen Wruck, and Perry Fagan. "Value Creation: Abridged." Harvard Business School Case 898-185, March 1998.
- May 2022 (Revised April 2024)
- Case
Third Point in 2020: Growth Is Where the Value Is?
By: Robin Greenwood, James Williams and Denise Han
In early May 2020, Daniel Loeb’s team at Third Point was evaluating a potential growth opportunity in the Walt Disney Company and whether investor activism might play a role. Battered by the effects of COVID-19, the company’s stock had initially tumbled to $86 and then... View Details
Keywords: Growth; Equity; Disney; Value; COVID-19 Pandemic; Economics; Strategy; Growth and Development; Investment Return; Opportunities; Business and Stakeholder Relations; North America
Greenwood, Robin, James Williams, and Denise Han. "Third Point in 2020: Growth Is Where the Value Is?" Harvard Business School Case 222-029, May 2022. (Revised April 2024.)
- Article
Capturing Value from Intellectual Property (IP) in a Global Environment
By: Juan Alcácer, Karin Beukel and Bruno Cassiman
Globalization should provide firms with an opportunity to leverage their know-how and reputation across countries to create value. However, it remains challenging for them to actually capture that value using traditional Intellectual Property (IP) tools. In this paper,... View Details
Keywords: Appropriation Strategy; Counterfeit; Intellectual Property Rights; Litigation; Value Capturing; Intellectual Property; Rights; Value; Lawsuits and Litigation; Global Range; Situation or Environment
Alcácer, Juan, Karin Beukel, and Bruno Cassiman. "Capturing Value from Intellectual Property (IP) in a Global Environment." Special Issue on Geography, Location, and Strategy. Advances in Strategic Management 36 (2017): 163–228.
- October 2000
- Case
Tree Values
By: Richard S. Ruback and Kathleen Luchs
Describes two alternative tree cutting strategies. The first is to cut all trees that are at least 12 inches in diameter at breast height. The second is to thin the forest by cutting less desirable trees immediately and harvesting the crop trees later. The case... View Details
Keywords: Strategy; Decision Making; Cash Flow; Decision Choices and Conditions; Management Practices and Processes; Value Creation; Forestry Industry
Ruback, Richard S., and Kathleen Luchs. "Tree Values." Harvard Business School Case 201-031, October 2000.
- February 1991 (Revised April 1994)
- Background Note
Value of Information
By: David E. Bell
Gives some simple examples to illustrate the concept of the value of information in decision making. Both perfect and imperfect information are considered. View Details
Bell, David E. "Value of Information." Harvard Business School Background Note 191-138, February 1991. (Revised April 1994.)
- Web
The Value
Whether it's improving leadership skills, staying abreast of industry innovations, or preparing for a new role, everyone has their own distinct reasons for coming to HBS Executive Education. Our unique approach to education enables you to reach your personal and... View Details
- Article
Creating Value Together
By: Maxim Sytch and Ranjay Gulati
Conventional wisdom suggests that companies should avoid growing dependent on their business partners. If one company, the thinking goes, grows too dependent on a counterpart by getting the entire input for a particular activity from it and is not able to switch... View Details
Keywords: Supply Chain Management; Performance Improvement; Partners and Partnerships; Power and Influence; Value Creation
Sytch, Maxim, and Ranjay Gulati. "Creating Value Together." Business Intelligence. MIT Sloan Management Review 50, no. 1 (Fall 2008): 12–13.
- Article
The Impact of Forward-Looking Metrics on Employee Decision-Making: The Case of Customer Lifetime Value
By: Pablo Casas-Arce, Asis Martinez Jerez and V.G. Narayanan
This paper analyzes the effects of forward-looking metrics on employee decision-making. We use data from a bank that started providing branch managers with the customer lifetime value (CLV)—an estimate of the future value of the customer relationship—of mortgage... View Details
Keywords: Customer Lifetime Value; Forward-looking Metrics; Employees; Decision Making; Information; Customer Value and Value Chain; Banks and Banking; Mortgages; Outcome or Result
Casas-Arce, Pablo, Asis Martinez Jerez, and V.G. Narayanan. "The Impact of Forward-Looking Metrics on Employee Decision-Making: The Case of Customer Lifetime Value." Accounting Review 92, no. 3 (May 2017): 31–56.
- Article
Valuing Customers
By: Sunil Gupta, Donald R. Lehmann and Jennifer A. Stuart
Gupta, Sunil, Donald R. Lehmann, and Jennifer A. Stuart. "Valuing Customers." Journal of Marketing Research (JMR) 41, no. 1 (February 2004): 7–18. (Winner of the 2009 William F. O'Dell award from the Journal of Marketing Research.)
- November 2020
- Supplement
Valuing Celgene's CVR
By: Benjamin C. Esty and Daniel Fisher
When Bristol-Myers Squibb (BMS) acquired Celgene Corporation in November 2019, Celgene shareholders received cash, BMS stock, and a contingent value right (CVRs) that would pay $9 if the U.S. Food and Drug Administration (FDA) approved three of Celgene’s late stage... View Details